What Are the Different Types of Pain?

Pain Is Not What You Think It Is

Most people understand pain intuitively as a signal from damaged tissue — a message from the body informing the brain that something has gone wrong. This model is intuitive, deeply embedded in everyday language, and — unfortunately — significantly incomplete. The contemporary scientific understanding of pain defines it as an output of the brain generated when the nervous system concludes that the body is under threat and that action is required. Pain is not simply transmitted from damaged tissue to a passive brain; it is actively constructed by the brain based on a complex integration of sensory information, memory, emotion, context, expectation, and biological state.

This distinction has profound clinical implications. It explains why people can have severe structural pathology and experience no pain, while others have minimal tissue damage and severe, disabling pain. It explains why pain can persist long after tissues have healed. And it explains why treatment directed exclusively at peripheral tissues is sometimes insufficient and must be complemented by approaches that address the nervous system itself.

Nociceptive Pain

Nociceptive pain arises from the activation of nociceptors — specialised sensory nerve endings throughout all body tissues that detect potentially tissue-damaging stimuli including mechanical stress, heat, cold, and chemical irritants. It is the most physiologically "normal" form of pain, arising in direct proportion to ongoing or threatened tissue damage and resolving as the tissue heals.

Nociceptive pain is subdivided into somatic and visceral forms. Somatic nociceptive pain, arising from skin, muscles, fascia, tendons, ligaments, and bone, is typically well-localised, sharp or aching in quality, and reliably provoked by specific movements or palpation. Visceral nociceptive pain, arising from internal organs, tends to be more diffuse, poorly localised, cramping or deep aching in quality, and may refer to distant somatic structures — a phenomenon clinicians must account for when unexplained musculoskeletal pain fails to respond to mechanical assessment and treatment. Nociceptive pain generally correlates with tissue state — better with rest, worse with provocative loads — and diminishes predictably as healing advances.

Neuropathic Pain

Neuropathic pain is defined by the IASP as pain arising directly from a lesion or disease affecting the somatosensory nervous system. Rather than reflecting tissue damage detected by intact nociceptors, neuropathic pain is generated by abnormal activity within the nerve itself due to injury, compression, inflammation, or metabolic disruption.

The hallmarks include a burning, shooting, electric, or lancinating quality; allodynia (pain produced by stimuli not normally painful, such as light touch); hyperalgesia (exaggerated pain response to normally mildly painful stimuli); dermatomal or peripheral nerve distribution; and associated neurological signs including altered sensation, motor weakness, or changes in deep tendon reflexes. Common musculoskeletal presentations with a neuropathic component include cervical and lumbar radiculopathy, carpal tunnel syndrome, cubital tunnel syndrome, and thoracic outlet syndrome. Treatment must address both the mechanical source of nerve compromise and the altered neural tissue itself through neurodynamic mobilisation alongside management of the compressive or inflammatory driver.

Nociplastic Pain

Nociplastic pain — formally defined by the IASP in 2017 — describes pain arising from altered nociception without clear evidence of actual or threatened tissue damage activating nociceptors, and without evidence of nerve damage causing neuropathic pain. It captures the experience of pain driven primarily by changes in the central nervous system rather than ongoing peripheral pathology.

The underlying mechanism is central sensitisation: a state of heightened excitability in the central nervous system's pain-processing circuits. Stimuli the nervous system would normally process as innocuous are interpreted as threatening; actual painful stimuli produce a response disproportionate to their intensity; pain may spread beyond the original injury site. Woolf's (2011) landmark review describes the neurophysiological changes in detail — synaptic strengthening in the dorsal horn, reduced inhibitory interneurone activity, descending pain facilitation from the brainstem, and cortical reorganisation. These changes are real, measurable, and — importantly — modifiable. Conditions with a prominent nociplastic component include fibromyalgia, chronic widespread pain, persistent post-surgical pain, and some presentations of chronic low back pain and whiplash. Treatment requires a fundamentally different approach — prioritising pain neuroscience education, graded activity exposure, psychological support, and sleep management.

Mixed Pain States

Clinical reality is rarely as clean as textbook categories suggest. Many presentations involve elements of two or all three pain types simultaneously — and this mixture changes over time as the condition evolves. A client who sustains a lumbar disc herniation may initially present with nociceptive pain from the disc tissue and neuropathic pain from nerve root irritation; if poorly managed, central sensitisation may develop, introducing a nociplastic component that persists even after the disc has resorbed and the nerve root is no longer compressed. Accurate identification of the relative contribution of each pain mechanism requires skilled clinical assessment and directly shapes the treatment approach.

Acute vs Chronic Pain

Acute pain — typically defined as less than three months' duration — is closely correlated with the tissue healing timeline and biologically protective. Chronic pain, persisting beyond three months (or beyond expected healing time), increasingly reflects neurophysiological changes in pain processing rather than ongoing tissue pathology. The transition from acute to chronic pain is not inevitable — early, evidence-based management of acute musculoskeletal pain, addressing both peripheral tissue and the psychosocial factors that predict chronicity (fear-avoidance, catastrophising, poor sleep, passive coping), substantially reduces the risk of pain persistence.

Why Classification Matters for Treatment

Understanding the type of pain driving a presentation directly determines which treatments are most likely to help, in what sequence, and at what intensity. Nociceptive pain responds well to mechanical loading management and hands-on treatment of the peripheral tissue. Neuropathic pain requires neural mobilisation and decompression. Nociplastic pain needs a brain-and-nervous-system directed approach that cannot be delivered by tissue treatment alone. Receiving care from a clinician who understands and actively assesses pain mechanisms — rather than treating all pain as a tissue problem to be fixed — is one of the most important factors determining whether the treatment you receive is appropriate to what your nervous system actually needs.